Skip to the content Skip to the Navigation
GEXVal
  • HOME
  • Our company
    • CEO message
    • Corporate philosophy
    • Origin of the company name
    • Corporate symbol and color
    • Company profile
    • Team
  • Business Model
  • Pipeline
  • To investors
  • News
    • IR
    • Information
    • R&D
  • Contact
  • Language
    • 日本語
    • English
    • 中文 (簡体字)
    • 中文 (繁体字)

News

  1. Top page
  2. News
Information
CTO Nakayama to Participate in the 7th Annual Meeting of the Japanese Association for Medical Artificial Intelligence, June 27–28, 2025, at Kyoto International Conference Center
2025/6/24

Read more
Information
GEXVal to Participate in BIO International Convention 2025
2025/6/5

Read more
Information
GEXVal to Present at Bio€quity Europe 2025
2025/5/12

Read more
Information
Data-Driven Drug Discovery Platform "RePhaIND®" to be Presented at the Pharmaceutical Society of Japan Annual Meeting
2025/3/14

GEXVal Inc.March 14, 2025   Data-Driven Drug Discovery Platform "RePhaIND®︎" to be Presented at the Pharmaceut […]

Read more
Information
GEXVal to Participate in BIO-EUROPE SPRING® (MILAN) 2025
2025/3/1

Read more

Posts pagination

  • «
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • …
  • Page 20
  • »

Category

  • Information
  • IR
  • R&D

Copyright © GEXVal All Rights Reserved.

Powered by WordPress with Lightning Theme & VK All in One Expansion Unit

MENU
  • HOME
  • Our company
    • CEO message
    • Corporate philosophy
    • Origin of the company name
    • Corporate symbol and color
    • Company profile
    • Team
  • Business Model
  • Pipeline
  • To investors
  • News
    • IR
    • Information
    • R&D
  • Contact
  • Language
    • 日本語
    • English
    • 中文 (簡体字)
    • 中文 (繁体字)